VSEE director granted 40,107 company shares

O'SULLIVAN COLIN P. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/06/2026 - 04:31 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

O'SULLIVAN COLIN P. reported acquisition or exercise transactions in this Form 4 filing.

VSEE HEALTH, INC. director Colin P. O'Sullivan reported an award of 40,107 shares of common stock, granted under the company’s 2024 Incentive Plan as compensation for his board service for the quarter ended December 31, 2025.

The number of shares was based on the common stock closing price on December 31, 2025, and after this grant he directly owns 108,731 shares of VSEE common stock.

Insider Trade Summary

Grant/Award: 40,107 shares

Grant/Award 1 txn

Insider O'SULLIVAN COLIN P.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001 per share	40,107	$0.374	$15K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 108,731 shares (Direct)

Holdings Before and After: Common Stock, par value $0.0001 per share, 68,624 to 108,731 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan in accordance with the issuer's non-employee director compensation policy for services as a director during the quarter ended December 31, 2025. The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VSEE (VSEE) report for Colin P. O'Sullivan?

VSEE reported that director Colin P. O'Sullivan received an award of 40,107 shares of common stock. The shares were granted as part of his non-employee director compensation for serving on the board during the quarter ended December 31, 2025.

How many VSEE (VSEE) shares does Colin P. O'Sullivan own after this Form 4?

After the reported grant, Colin P. O'Sullivan directly owns 108,731 shares of VSEE common stock. This total reflects the addition of 40,107 shares awarded under the company’s 2024 Incentive Plan for his non-employee director service.

What was the basis for calculating the 40,107-share grant to VSEE (VSEE) director O'Sullivan?

The 40,107-share grant to Colin P. O'Sullivan was calculated using the closing price of VSEE common stock on December 31, 2025. This price determined how many shares he received as compensation for his director service that quarter.

Under which plan was the VSEE (VSEE) stock granted to director Colin P. O'Sullivan?

The shares granted to Colin P. O'Sullivan were issued under VSEE’s 2024 Incentive Plan. The award was made according to the company’s non-employee director compensation policy for service during the quarter ended December 31, 2025.

Was the VSEE (VSEE) Form 4 transaction a market purchase or a grant?

The Form 4 shows a grant or award acquisition, not an open-market purchase. Colin P. O'Sullivan received 40,107 shares as equity compensation under the 2024 Incentive Plan for his non-employee director service during the specified quarter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'SULLIVAN COLIN P.

(Last) (First) (Middle)

C/O VSEE HEALTH, INC.

980 N FEDERAL HWY #304

(Street)

BOCA RATON FL 33432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VSEE HEALTH, INC. [ VSEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	03/04/2026		A		40,107	A	$0.374(1)	108,731	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan in accordance with the issuer's non-employee director compensation policy for services as a director during the quarter ended December 31, 2025. The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.

	/s/ Colin P. O'Sullivan	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.